About Us //

Structure & Funding

The Maurice Wilkins Centre is guided by top scientists and entrepreneurs and funded by the New Zealand Government.

Structure

The Maurice Wilkins Centre is led by eight principal investigators, who together make up its Management Committee. It has five further incoming principal investigators, who will be appointed from within its network and take up their positions on the Management Committee from 2015. The Centre brings together more than 140 associate investigators and 170 affiliate investigators, based at research institutions around the country.

It is overseen by the Maurice Wilkins Centre Board, which meets three times a year to monitor the progress of its research programmes, outreach and education outcomes, and compliance with its funding mandate and budget. The Board also provides advice on the development of the Centre’s research and on matters of administration, external relations and international engagement.

In addition the Centre benefits from the guidance of its Scientific Advisory Board, which comprises seven internationally recognised scientists and bio-entrepreneurs. The Scientific Advisory Board meets biennially to review the Centre’s research programme and advise on future directions.

The Centre’s day to day operations are run by an Executive Team headquartered at its host institution, the University of Auckland.

Funding

The Maurice Wilkins Centre is one of seven New Zealand Centres of Research Excellence (CoREs). It was established with Government funding in 2002 to underpin world-class research efforts in New Zealand. CoRE funding is determined through a fully contestable process, and is allocated and monitored by the Tertiary Education Committee (TEC).

In addition to CoRE funding, Maurice Wilkins Centre investigators have a proven track record of accessing other financial resources, including through contestable funding rounds and contract research. Its network facilitates the establishment of internationally competitive teams that can access a variety of funding sources, and improves the efficiency of New Zealand biomedical research funding by strategically aligning the research programmes of its investigators.